Using triple radio-immunotherapy to overcome cancer immunotherapy resistance

作     者：Zengfu Zhang Xiaodong Zhang Dawei Chen Zengfu Zhang;Xiaodong Zhang;Dawei Chen

作者机构：Department of Radiation OncologyShandong University Cancer CenterJinan 250117China Department of Radiation OncologyShandong Cancer Hospital and InstituteShandong First Medical University and Shandong Academy of Medical SciencesJinan 250117China 

出 版 物：《Cancer Biology & Medicine》 (癌症生物学与医学（英文版）)

年 卷 期：2023年第20卷第11期

页      面：788-794页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

基　　金：supported by grants from the National Natural Science Foundation of China(Grant No.82172676) the Natural Science Foundation of Shandong(Grant No.ZR2021YQ52) 

主　　题：immunotherapy clinical cancer 

摘      要：Cancer is a widespread public health issue and has become a leading cause of death in most *** recent decades,immunotherapy,particularly the use of immune checkpoint inhibitors(ICIs),has altered the clinical practice of cancer treatment and evolved into a first-line clinical strategy.